-+ 0.00%
-+ 0.00%
-+ 0.00%

Proteome Sciences Confirms Receipt of Significant Clinical Contract for Chemoproteomics Platform

MT Newswires·09/15/2026 06:23:23
Listen to the news
06:23 AM EDT, 09/15/2026 (MT Newswires) -- Proteome Sciences (PRM.L) confirmed it has secured the significant clinical contract for its chemoproteomics platform, initially announced in June. The contract proteomics services company expected the contract to serve as a precursor to a new clinical trial program in 2026, which it will carry out at its laboratories in Frankfurt, Germany, in line with Good Clinical Laboratory Practice accreditation. Proteome Sciences expects the majority of the work in the contract to be completed in 2027.